Auro Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 239365,
    "name": "Auro Labs.",
    "stock_name": "Auro Labs.",
    "full_name": "Auro Laboratories Ltd",
    "name_url": "stocks-analysis/auro-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "233.55",
    "chg": -6,
    "chgp": "-2.5%",
    "dir": -1,
    "prev_price": "239.55",
    "mcapval": "148.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530233,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE292C01011",
    "curr_date": "Aug 27, 11:37 AM",
    "curr_time": "11:42 AM",
    "last_traded_at": "Aug 27, 11:37 AM IST",
    "bse_nse_vol": "270 ",
    "exc_status": "Active",
    "traded_date": "Aug 27, 2026",
    "traded_date_str": "2026 08 27",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/auro-labs-239365-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Auro Laboratories Ltd Valuation Shifts Signal Heightened Price Risk",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-ltd-valuation-shifts-signal-heightened-price-risk-4170728",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AuroLaboratorie_valuationdot_4170728.png",
        "date": "2026-08-27 08:00:26",
        "description": "Auro Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift notably, with its price-to-earnings (P/E) and price-to-book value (P/BV) ratios moving into the 'very expensive' category. Despite this, the stock has delivered mixed returns relative to the broader Sensex index, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Auro Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-strong-sell-4164852",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AuroLaboratorie_mojoScore_4164852.png",
        "date": "2026-08-22 10:10:28",
        "description": "Auro Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 July 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 22 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Auro Laboratories Ltd Valuation Shifts Signal Price Attractiveness Change",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-ltd-valuation-shifts-signal-price-attractiveness-change-4158442",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AuroLaboratorie_valuationdot_4158442.png",
        "date": "2026-08-18 08:00:20",
        "description": "Auro Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its valuation parameters, prompting a reassessment of its price attractiveness. With its price-to-earnings (P/E) ratio moving from very expensive to expensive territory and a recent downgrade in its Mojo Grade to Strong Sell, investors are urged to carefully analyse the evolving fundamentals and relative valuation metrics against peers and historical benchmarks."
      },
      {
        "title": "When is the next results date for Auro Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-auro-laboratories-ltd-4148712",
        "imagepath": "",
        "date": "2026-08-11 23:17:14",
        "description": "The next results date for Auro Laboratories Ltd is scheduled for 14 August 2026...."
      },
      {
        "title": "Auro Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-strong-sell-4147211",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AuroLaboratorie_mojoScore_4147211.png",
        "date": "2026-08-11 10:10:57",
        "description": "Auro Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 11 August 2026, providing investors with the most up-to-date insight into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Auro Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-ltd-forms-death-cross-signalling-potential-bearish-trend-4140313",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AuroLaboratorie_dealthcross_4140313.png",
        "date": "2026-08-06 18:00:27",
        "description": "Auro Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s medium to long-term outlook."
      },
      {
        "title": "Auro Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-strong-sell-4130019",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AuroLaboratorie_mojoScore_4130019.png",
        "date": "2026-07-31 10:11:38",
        "description": "Auro Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Auro Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-strong-sell-4108933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AuroLaboratorie_mojoScore_4108933.png",
        "date": "2026-07-20 10:10:58",
        "description": "Auro Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Auro Laboratories Ltd Downgraded to Strong Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-downgraded-to-strong-sell-amid-technical-weakness-and-valuation-concerns-4094493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AuroLaboratorie_mojoScore_4094493.png",
        "date": "2026-07-09 08:06:22",
        "description": "Auro Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 8 July 2026, reflecting a marked deterioration in its technical outlook and persistent fundamental challenges. Despite a positive quarterly financial performance, the company’s valuation, financial trends, and technical indicators have collectively triggered this reassessment, signalling caution for investors in this micro-cap pharmaceutical player."
      }
    ],
    "total": 177,
    "sid": "239365",
    "stock_news_url": "https://www.marketsmojo.com/news/auro-laboratories-239365"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Aug-2026",
      "details": "Auro Laboratories Limited has submitted the clippings of newspaper publications of the Un-audited Financial Results for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On August 14 2026.",
      "datetime": "14-Aug-2026",
      "details": "Auro Laboratories Limited has submitted the Outcome of the Board Meeting held on August 14 2026",
      "source": "BSE"
    },
    {
      "caption": " Un-Audited Financial Results For The Quarter Ended June 30 2026.",
      "datetime": "14-Aug-2026",
      "details": "Auro Laboratories Limited has submitted the Unaudited Financial Results for the Quarter ended June 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Auro Laboratories Ltd Valuation Shifts Signal Heightened Price Risk

2026-08-27 08:00:26

Auro Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift notably, with its price-to-earnings (P/E) and price-to-book value (P/BV) ratios moving into the 'very expensive' category. Despite this, the stock has delivered mixed returns relative to the broader Sensex index, prompting a reassessment of its investment appeal.

Read full news article

Auro Laboratories Ltd is Rated Strong Sell

2026-08-22 10:10:28

Auro Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 July 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 22 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Auro Laboratories Ltd Valuation Shifts Signal Price Attractiveness Change

2026-08-18 08:00:20

Auro Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its valuation parameters, prompting a reassessment of its price attractiveness. With its price-to-earnings (P/E) ratio moving from very expensive to expensive territory and a recent downgrade in its Mojo Grade to Strong Sell, investors are urged to carefully analyse the evolving fundamentals and relative valuation metrics against peers and historical benchmarks.

Read full news article

When is the next results date for Auro Laboratories Ltd?

2026-08-11 23:17:14

The next results date for Auro Laboratories Ltd is scheduled for 14 August 2026....

Read full news article

Auro Laboratories Ltd is Rated Strong Sell

2026-08-11 10:10:57

Auro Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 11 August 2026, providing investors with the most up-to-date insight into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Auro Laboratories Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-08-06 18:00:27

Auro Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock’s medium to long-term outlook.

Read full news article

Auro Laboratories Ltd is Rated Strong Sell

2026-07-31 10:11:38

Auro Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Auro Laboratories Ltd is Rated Strong Sell

2026-07-20 10:10:58

Auro Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Auro Laboratories Ltd Downgraded to Strong Sell Amid Technical Weakness and Valuation Concerns

2026-07-09 08:06:22

Auro Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 8 July 2026, reflecting a marked deterioration in its technical outlook and persistent fundamental challenges. Despite a positive quarterly financial performance, the company’s valuation, financial trends, and technical indicators have collectively triggered this reassessment, signalling caution for investors in this micro-cap pharmaceutical player.

Read full news article

View All News